'B19 dna' presentation slideshows

252 views • 16 slides

Outline

Parvovirus B19 NAT for Whole Blood and Source Plasma Introduction and Background Mei-ying W Yu, PhD DH/OBRR/CBER/FDA 75 th Blood Products Advisory Committee. Outline. Introduction and Background Overview of Parvovirus B19 Infection Kevin Brown, MD, NHLBI/NIH Industry Data Presentations

295 views • 16 slides

Outline

Parvovirus B19 NAT for Whole Blood and Source Plasma Introduction and Background Mei-ying W Yu, PhD DH/OBRR/CBER/FDA 75 th Blood Products Advisory Committee. Outline. Introduction and Background Overview of Parvovirus B19 Infection Kevin Brown, MD, NHLBI/NIH Industry Data Presentations

271 views • 16 slides

M Busch, representing REDS-II Parvo B19 protocol team

Transmissibility of B19 by transfusion: evaluation of donor viremia prior to performing a linked donor-recipient study. M Busch, representing REDS-II Parvo B19 protocol team. RADAR Repository. Established from 2000-2003 in seven US cities NHLBI and CDC funded

267 views • 12 slides

Level of viraemia and genotype characteristics of Parvo B19 in blood donors and patients

Level of viraemia and genotype characteristics of Parvo B19 in blood donors and patients. Brojer E, Grabarczyk P Depatment of Immuhematology Institute of Hematology and Blood Transfusion, Warsaw, Poland. Parvo B19 testing in IHBT. MATERIALS

95 views • 9 slides

Laboratory of Plasma Derivatives Safety and Quality Control Section

Laboratory of Plasma Derivatives Safety and Quality Control Section. Principal Investigator: Mei-ying W. Yu, PhD. Research Projects. Safety and QC Standards Parvovirus B19 (5 studies)

224 views • 7 slides

196 views • 7 slides